News Article
Jul 10, 2012
ReViral Project Shortlisted for Wellcome Trust SDDI Award

ReViral have been successful in securing a review by the Wellcome Trust Technology Transfer Challenge Committee for the Company project entitled ‘A stream-lined lead optimization project with the potential to deliver first in class small molecule inhibitors of Respiratory Syncitial Virus (RSV)’ The final decision for the SDDI award will be made in October 2012.